查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1997117

介入放射學產品市場​​：依產品類型、應用、最終用戶和通路分類－2026-2032年全球市場預測

Interventional Radiology Products Market by Product Type, Application, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2025 年介入放射學產品市場​​價值為 127 億美元，預計到 2026 年將成長至 135.3 億美元，複合年成長率為 6.61%，到 2032 年將達到 198.8 億美元。

主要市場統計數據
基準年 2025 127億美元
預計年份：2026年 135.3億美元
預測年份 2032 198.8億美元
複合年成長率 (%) 6.61%

本書權威地介紹了設備創新、臨床需求和不斷變化的醫療保健環境如何重塑介入放射學的全球生態系統。

介入放射學在臨床需求、醫療設備創新和醫療保健系統變革的交會點上不斷發展。在影像、能量傳遞和栓塞劑技術的進步推動下，微創技術如今能夠治療更廣泛的疾病。臨床醫生越來越傾向於採用標靶治療，以減少手術併發症並縮短恢復時間，這重新定義了導管室和混合手術室中所有醫療設備的需求。

影像導引技術的創新、向門診護理的轉變、數位化整合以及供應鏈韌性如何全面改變臨床引入和商業策略。

多項變革正在重塑介入放射學的格局，並改變產品研發和商業化的進程。首先，影像導引和導航系統的成熟提高了手術精度，使得使用更小的器械和更複雜的解剖結構進行安全治療成為可能。同時，能量傳遞方式和栓塞材料的進步正推動著治療方式從一次性器械轉向整合影像、消融和栓塞功能於一體的綜合治療平台。

本研究評估了累積價格波動如何影響整個介入器材價值鏈中的區域製造策略、價格壓力和採購行為。

近期關稅趨勢對介入設備價值鏈產生了累積影響，迫使製造商和買家重新評估其採購和成本結構。關稅上漲和貿易摩擦加劇推高了進口零件和成品的到貨成本，迫使製造商重新考慮其供應商網路、材料選擇和區域製造地。因此，各企業面臨策略選擇：要麼自行承擔單位成本上漲，要麼使用替代零件重新設計產品，要麼將生產設施遷至更靠近終端市場的地方。

關鍵細分洞察概述了產品模式、臨床應用、醫療保健環境和分銷趨勢如何相互交織並影響其採用和商業化。

詳細的市場細分揭示了臨床需求和商業性機會在產品類型、應用、終端用戶通路和通路上的交匯點。從產品角度來看，熱消融設備與各種血管介入工具並存。微波和射頻系統提供獨特的消融特性，影響腫瘤消融通訊協定；而血管成形術用氣球、導管、導管導引線和支架則滿足了機械性重組的需求。栓塞療法包括可實現遠端介入的液體栓塞劑和可實現精確閉塞的顆粒栓塞劑，而用於頸動脈保護和周邊血管介入的支架設計也各不相同。

將全球主要市場的臨床需求、監管複雜性和生產重點與可行的商業化途徑聯繫起來的區域性洞察。

區域趨勢對醫療器材設計、監管策略和商業規劃有顯著影響。在美洲，醫療保健系統日益注重向價值醫療和門診護理模式轉型，從而推動了對具有更高成本效益和手術效率的醫療器材的需求。支付者的考量促使醫療器材提供嚴謹的療效數據，以支持其融入診療路徑；而大規模醫療保健系統的規模則往往更注重採購夥伴關係，包括培訓和長期服務合約。

公司和競爭對手資訊表明，平台策略、夥伴關係和主導商業化如何決定介入器材市場的永續主導地位。

企業策略日益著重於平台整合、有針對性的研發投資以及能夠縮短臨床試驗時間的選擇性夥伴關係。主要企業優先建構整合影像、治療執行和資訊服務的跨職能產品組合，而新興企業則專注於技術差異化與臨床需求交會的細分領域。醫療設備製造商 (OEM) 與軟體供應商之間的合作正在不斷拓展，共同打造互聯解決方案，以支持治療計劃、治療中指導和上市後療效追蹤。

為產業領導者提供切實可行的策略建議，以增強供應鏈韌性，加速門診治療的普及，並將實證臨床價值貨幣化。

產業領導者應優先考慮一系列切實可行的措施，以平衡短期韌性和長期成長。首先，他們需要實現生產和供應鏈地點的多元化，以減輕貿易中斷的影響並滿足區域監管要求。此策略應包括關鍵零件的雙重採購、高風險產品的選擇性近岸外包，以及與供應商簽訂風險共擔協議，以確保供應的連續性。

一種透明的、以臨床醫生為基礎的調查方法，結合與關鍵相關人員的對話、整合二手證據和嚴格的檢驗，以檢驗策略見解。

本調查方法結合了定性研究、二手資料整合和嚴謹的檢驗，以確保研究結果既基於臨床實際情況，也商業性實踐。一手數據透過對介入醫師、採購經理、醫院管理人員、門診手術中心營運人員和銷售合作夥伴在臨床環境中進行結構化訪談收集，以獲取關於臨床需求、採購因素和服務期望的第一手觀點。專家小組和臨床醫生顧問委員會檢驗臨床趨勢和醫療設備的性能特徵。

在不斷發展的介入治療領域，本書提供了明確的結論，整合了臨床、商業性和營運要素，從而製定了致勝策略。

這些分析共同表明，市場正處於積極變革時期期，其特徵是技術日趨成熟、醫療服務模式向低成本方向轉變，以及對具有韌性的商業和生產模式的需求。兼顧手術療效和營運效率的醫療設備創新將日益受到臨床醫生和採購團隊的關注。同時，地緣政治和貿易因素也凸顯了多元化供應鏈和針對當地情況量身定做的打入市場策略的重要性。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 介入放射學產品市場​​：依產品類型分類

  • 消融裝置
    • 微波消融裝置
    • 射頻消融術裝置
  • 用於血管生成的球囊
  • 導管
  • 栓塞劑
    • 液態栓塞劑
    • 顆粒栓子
  • 栓塞線圈
  • 導管導引線
  • 血管閉合裝置
  • 血管支架
    • 頸動脈支架
    • 周邊血管支架

第9章 介入放射學產品市場​​：依應用領域分類

  • 介入神經放射學
    • 動脈瘤栓塞術
    • 中風血栓切除術
  • 腫瘤干預
    • 經動脈化療栓塞術
    • 腫瘤消融
      • 冷凍消融術
      • 微波消融裝置
      • 射頻消融術裝置
  • 疼痛管理
  • 血管介入

第10章 介入放射學產品市場​​：依最終用戶分類

  • 門診手術中心
  • 診所
  • 醫院

第11章 介入性放射學產品市場​​：依分銷管道分類

  • 直銷
  • 透過分銷商銷售

第12章 介入放射學產品市場​​：按地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章 介入放射學產品市場​​：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 介入性放射學產品市場​​：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章：美國介入放射學產品市場

第16章：中國介入放射學產品市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Abbott Laboratories
  • B. Braun SE
  • Becton, Dickinson and Company
  • BIOTRONIK SE & Co. KG
  • Boston Scientific Corporation
  • Cardinal Health, Inc.
  • Cook Medical LLC
  • GE HealthCare
  • Koninklijke Philips NV
  • Medtronic plc
  • Merit Medical Systems, Inc.
  • Siemens Healthineers AG
  • Stryker Corporation
  • Teleflex Incorporated
  • Terumo Corporation
Product Code: MRR-46132FF7A845

The Interventional Radiology Products Market was valued at USD 12.70 billion in 2025 and is projected to grow to USD 13.53 billion in 2026, with a CAGR of 6.61%, reaching USD 19.88 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 12.70 billion
Estimated Year [2026] USD 13.53 billion
Forecast Year [2032] USD 19.88 billion
CAGR (%) 6.61%

An authoritative introduction to how device innovation, clinical demand, and care setting shifts are reshaping the interventional radiology ecosystem globally

Interventional radiology continues to evolve at the intersection of clinical need, device innovation, and health system transformation. Minimally invasive techniques now address a broader range of pathologies, driven by advances in imaging, energy delivery, and embolic chemistries. Clinicians increasingly prefer targeted interventions that reduce procedural morbidity and shorten recovery time, which in turn redefines demand across the spectrum of devices used in the catheterization laboratory and hybrid suites.

This narrative encompasses a diverse product landscape that includes thermal ablation platforms, angioplasty balloons, catheters, embolic agents, embolization coils, guidewires, vascular closure systems, and stent technologies. Within these categories, sub-specialized modalities such as microwave and radiofrequency ablation, liquid and particulate embolics, and carotid versus peripheral stent designs create distinct clinical value propositions. Applications span neurovascular procedures through aneurysm management and stroke thrombectomy, oncology interventions via transarterial chemoembolization and tumor ablation, pain management techniques, and a broad range of vascular interventions.

End users vary from hospitals to ambulatory surgical centers and clinics, each presenting unique procedural volumes, purchasing behaviors, and capital equipment constraints. Distribution pathways that rely on either direct sales models or distributor networks further shape product adoption curves. Taken together, these elements form the foundation for the analysis that follows, setting context for how device innovation, care setting migration, and commercialization strategies will determine competitive advantage and clinical impact.

How image-guided innovation, outpatient migration, digital integration, and supply chain resilience are collectively transforming clinical adoption and commercial strategy

Several transformative shifts are redefining the interventional radiology landscape and altering the trajectory of product development and commercialization. First, the maturation of image guidance and navigation systems has elevated procedural precision, enabling smaller devices and more complex anatomies to be treated safely. Concurrently, energy delivery modalities and embolic materials are becoming more sophisticated, which supports a movement from single-use instruments toward integrated therapy platforms that combine imaging, ablation, and embolization capabilities.

The migration of procedures to outpatient settings and ambulatory surgical environments is accelerating demand for compact, cost-efficient systems and streamlined workflows. This transition interacts with end-user purchasing preferences and capital allocation, prompting manufacturers to rethink product form factors and service models. At the same time, digital augmentation, including procedure analytics and device connectivity, is emerging as a differentiator for long-term clinician engagement and post-market surveillance.

Supply chain resilience and regulatory expectations are also shifting. Manufacturers are investing in regional manufacturing and quality systems to reduce exposure to disruptions, and health systems are demanding stronger evidence of clinical benefit and cost-effectiveness. These changes create both constraints and opportunities: they compress time-to-adoption for solutions that demonstrate clear value while increasing barriers for commoditized products without differentiated clinical advantage.

Assessing how cumulative tariff shifts have catalyzed regional manufacturing strategies, pricing pressure, and procurement behaviors across the interventional device value chain

Recent tariff dynamics have exerted a cumulative impact on the interventional device value chain, prompting manufacturers and purchasers to reassess sourcing and cost structures. Increased duties and trade frictions raise the landed cost of imported components and finished products, which places pressure on manufacturers to re-evaluate supplier networks, materials choice, and regional manufacturing footprints. As a result, organizations face a strategic choice between absorbing higher unit costs, re-engineering products for alternative components, or shifting production closer to end markets.

These pressures ripple through distribution models: direct sales organizations may confront margin compression and longer procurement cycles as hospitals and ambulatory centers scrutinize purchased capital, while distributor-led channels contend with inventory re-pricing and contractual renegotiations. Clinicians and procurement teams respond by prioritizing multi-functional platforms and solutions that reduce procedure time and overall episode cost, thereby offsetting device price inflation with demonstrable clinical and economic benefits.

In response, manufacturers can adopt adaptive pricing strategies, secure longer-term supply agreements, and pursue localized manufacturing partnerships to stabilize cost structures. Meanwhile, stronger clinical evidence and outcomes documentation become essential tools to defend pricing and justify product selection during procurement deliberations. Collectively, these responses shape a more resilient and regionally balanced manufacturing and commercial model for interventional devices.

Key segmentation insights outlining how product modalities, clinical applications, care settings, and distribution dynamics intersect to shape adoption and commercialization

Detailed segmentation reveals where clinical demand and commercial opportunity converge across product types, applications, end-user channels, and distribution pathways. From a product perspective, thermal ablation devices coexist with a broad array of vascular tools: microwave and radiofrequency systems deliver distinct ablative profiles that influence tumor ablation protocols, while angioplasty balloons, catheters, guidewires, and stents address mechanical revascularization needs. Embolic therapies vary between liquid embolics that enable distal penetration and particulate agents that provide calibrated occlusion, and stent designs differentiate between carotid protection and peripheral vessel scaffolding.

Application-driven dynamics show that neuro interventions such as aneurysm embolization and stroke thrombectomy require ultra-high reliability and rapid device availability, whereas oncology interventions leverage both transarterial chemoembolization and tumor ablation approaches that depend on synergy between embolic materials and energy sources. Pain management procedures demand precise lesion targeting with minimal collateral tissue damage, and vascular interventions span a wide spectrum of acute and chronic indications that influence device specifications and adjunctive therapies.

End users exhibit divergent purchasing behaviors and procedural settings. Hospitals typically favor comprehensive platforms with full-service support, ambulatory surgical centers seek compact and cost-effective systems optimized for throughput, and clinics focus on devices that enable same-day procedures with predictable outcomes. Distribution choices between direct sales and distributor networks affect post-sale service expectations, training commitments, and inventory management, shaping how manufacturers structure commercial operations and training investments.

Regional intelligence that connects clinical demand, regulatory complexity, and manufacturing priorities to actionable commercialization pathways across key global markets

Regional dynamics exert a powerful influence on device design, regulatory strategy, and commercial planning. In the Americas, health systems are increasingly focused on value-based care and outpatient migration, driving demand for devices that demonstrate cost-efficiency and procedural throughput gains. The payer landscape encourages rigorous outcomes data to support inclusion in care pathways, and the scale of large health systems emphasizes purchasing partnerships that include training and long-term service agreements.

Across Europe, Middle East & Africa, the regulatory environment and reimbursement architectures present a mosaic of requirements that reward clinical evidence and interoperability. Procurement cycles can be longer and more fragmented, but opportunities exist for devices that meet diverse clinical needs while conforming to regional standards and local manufacturing expectations. In addition, healthcare capacity constraints in some markets accelerate adoption of less invasive therapies that reduce hospital stay and intensive care utilization.

Asia-Pacific is characterized by rapid infrastructure investment, expanding procedural volumes, and a growing middle-class demand for advanced therapies. Local manufacturing capabilities and partnerships often determine market access, and agility in pricing and service models can be a decisive differentiator. Across all regions, pragmatic localization of clinical evidence, regulatory dossiers, and supply chain strategies remains essential to converting clinical interest into sustained adoption.

Corporate and competitive intelligence showing how platform strategies, partnerships, and evidence-led commercialization determine sustainable advantage in interventional device markets

Corporate strategies are increasingly centered on platform consolidation, focused R&D investment, and selective partnerships that accelerate time to clinical adoption. Leading organizations prioritize cross-functional portfolios that integrate imaging, therapy delivery, and data services, while emerging companies target niche indications where technical differentiation and clinical need intersect. Collaboration between device OEMs and software providers is expanding, yielding connected solutions that support procedural planning, intra-procedural guidance, and post-market outcomes tracking.

Mergers and acquisitions remain a tactical route to acquire complementary technologies and receptive customer bases, but acquirers emphasize fit with existing service models and regulatory footprints. Contract manufacturing and strategic outsourcing reduce capital intensity but require rigorous quality oversight to maintain device reliability. Companies that invest early in clinical evidence generation and in-field training resources tend to secure durable clinician loyalty and smoother procurement approvals.

From a commercial perspective, firms that align pricing models with documented reductions in procedure time, hospital stay, or repeat interventions create stronger value propositions. Additionally, organizations that build scalable support infrastructures for ambulatory settings and clinics capture growth as care migrates out of traditional hospitals. Ultimately, corporate agility in R&D prioritization, channel management, and evidence development determines competitive positioning in this evolving marketplace.

Actionable strategic recommendations for industry leaders to build supply resilience, accelerate outpatient adoption, and monetize evidence-driven clinical value

Industry leaders should prioritize a set of pragmatic actions that balance short-term resilience with long-term growth. First, diversify manufacturing and supply chain footprints to reduce exposure to trade disruptions and to accommodate localized regulatory requirements. This strategy should include dual sourcing of critical components, selective nearshoring for high-risk items, and collaborative supplier risk-sharing arrangements to protect continuity of supply.

Second, invest in clinical evidence generation that clearly ties device performance to patient outcomes and total episode-of-care economics. High-quality registries, pragmatic clinical trials, and strong post-market surveillance enable more effective reimbursement conversations and support adoption in value-oriented health systems. Third, reconfigure product portfolios to address the outpatient migration trend by developing compact, service-light platforms that maintain clinical efficacy while reducing capital and operational burden for ambulatory centers and clinics.

Fourth, strengthen channel strategies by calibrating direct sales and distributor models to regional market realities, ensuring training and service capabilities match end-user expectations. Fifth, leverage digital tools for procedure analytics, remote training, and device connectivity to deepen clinician engagement and to create recurring service revenue. Finally, adopt adaptive pricing and contracting frameworks that align commercial terms with demonstrated clinical value, enabling more predictable procurement outcomes in price-sensitive environments.

A transparent, clinician-anchored methodology blending primary stakeholder engagement, secondary evidence synthesis, and rigorous triangulation to validate strategic insights

The research methodology combines primary qualitative engagement, secondary data integration, and rigorous triangulation to ensure findings are grounded in both clinical reality and commercial practice. Primary inputs include structured interviews with practicing interventionalists, procurement leaders, hospital administrators, ambulatory surgical center operators, and distributor partners to capture firsthand perspectives on clinical needs, purchasing drivers, and service expectations. Expert panels and clinician advisory boards provide validation of clinical trends and device performance characteristics.

Secondary research synthesizes peer-reviewed literature, clinical registries, regulatory filings, and product technical documentation to map technology attributes and historical adoption trajectories. Where available, procedure coding trends and published outcomes data inform the assessment of clinical pathways, while analyses of supply chain flows and trade patterns support evaluation of manufacturing and distribution risk. Data are cross-validated through multiple sources and reconciled with primary stakeholder feedback to reduce bias.

The segmentation framework is applied systematically across product, application, end-user, and distribution dimensions to identify areas of convergence between clinical need and commercial feasibility. Limitations and assumptions are documented transparently, and sensitivity checks are performed to test how alternative scenarios affect strategic implications. Ongoing stakeholder engagement is recommended to refine insights as new clinical evidence and policy developments emerge.

A decisive conclusion synthesizing clinical, commercial, and operational vectors that define winning strategies in the evolving landscape of interventional therapies

The collective analysis underscores a market in active transition, characterized by technological refinement, migration of care to lower-cost settings, and a need for resilient commercial and manufacturing models. Device innovation that couples procedural efficacy with operational efficiency will command heightened interest from clinicians and procurement teams alike. At the same time, geopolitical and trade considerations have elevated the importance of diversified supply chains and regionally attuned go-to-market strategies.

Success will favor organizations that combine robust clinical evidence with adaptable product platforms, deliver compelling total cost-of-care narratives, and execute disciplined channel and pricing strategies. Building trusted partnerships with clinicians, health systems, and distributors remains a critical differentiator that accelerates adoption and mitigates procurement friction. As clinical pathways evolve and new energy modalities and embolic chemistries gain traction, continuous investment in post-market data collection, training, and digital enablement will sustain competitive positioning.

Ultimately, the interplay of clinical need, regulatory expectations, and commercial agility defines the path forward. Stakeholders who align R&D priorities with demonstrated health system value and who invest in operational resilience will be best positioned to capture enduring clinical and commercial impact.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Interventional Radiology Products Market, by Product Type

  • 8.1. Ablation Devices
    • 8.1.1. Microwave Ablation Devices
    • 8.1.2. Radiofrequency Ablation Devices
  • 8.2. Angioplasty Balloons
  • 8.3. Catheters
  • 8.4. Embolic Agents
    • 8.4.1. Liquid Embolics
    • 8.4.2. Particulate Embolics
  • 8.5. Embolization Coils
  • 8.6. Guidewires
  • 8.7. Vascular Closure Devices
  • 8.8. Vascular Stents
    • 8.8.1. Carotid Stents
    • 8.8.2. Peripheral Vascular Stents

9. Interventional Radiology Products Market, by Application

  • 9.1. Neuro Intervention
    • 9.1.1. Aneurysm Embolization
    • 9.1.2. Stroke Thrombectomy
  • 9.2. Oncology Intervention
    • 9.2.1. Transarterial Chemoembolization
    • 9.2.2. Tumor Ablation
      • 9.2.2.1. Cryoablation
      • 9.2.2.2. Microwave Ablation Devices
      • 9.2.2.3. Radiofrequency Ablation Devices
  • 9.3. Pain Management
  • 9.4. Vascular Intervention

10. Interventional Radiology Products Market, by End User

  • 10.1. Ambulatory Surgical Centers
  • 10.2. Clinics
  • 10.3. Hospitals

11. Interventional Radiology Products Market, by Distribution Channel

  • 11.1. Direct Sales
  • 11.2. Distributor Sales

12. Interventional Radiology Products Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Interventional Radiology Products Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Interventional Radiology Products Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Interventional Radiology Products Market

16. China Interventional Radiology Products Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Abbott Laboratories
  • 17.6. B. Braun SE
  • 17.7. Becton, Dickinson and Company
  • 17.8. BIOTRONIK SE & Co. KG
  • 17.9. Boston Scientific Corporation
  • 17.10. Cardinal Health, Inc.
  • 17.11. Cook Medical LLC
  • 17.12. GE HealthCare
  • 17.13. Koninklijke Philips N.V.
  • 17.14. Medtronic plc
  • 17.15. Merit Medical Systems, Inc.
  • 17.16. Siemens Healthineers AG
  • 17.17. Stryker Corporation
  • 17.18. Teleflex Incorporated
  • 17.19. Terumo Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ABLATION DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ABLATION DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ABLATION DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ABLATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY MICROWAVE ABLATION DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY MICROWAVE ABLATION DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY MICROWAVE ABLATION DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ANGIOPLASTY BALLOONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ANGIOPLASTY BALLOONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ANGIOPLASTY BALLOONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY CATHETERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY CATHETERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY CATHETERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY EMBOLIC AGENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY EMBOLIC AGENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY EMBOLIC AGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY EMBOLIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY LIQUID EMBOLICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY LIQUID EMBOLICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY LIQUID EMBOLICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY PARTICULATE EMBOLICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY PARTICULATE EMBOLICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY PARTICULATE EMBOLICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY EMBOLIZATION COILS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY EMBOLIZATION COILS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY EMBOLIZATION COILS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY GUIDEWIRES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY GUIDEWIRES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY GUIDEWIRES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY VASCULAR CLOSURE DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY VASCULAR CLOSURE DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY VASCULAR CLOSURE DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY VASCULAR STENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY VASCULAR STENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY VASCULAR STENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY VASCULAR STENTS, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY CAROTID STENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY CAROTID STENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY CAROTID STENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY PERIPHERAL VASCULAR STENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY PERIPHERAL VASCULAR STENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY PERIPHERAL VASCULAR STENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY NEURO INTERVENTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY NEURO INTERVENTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY NEURO INTERVENTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY NEURO INTERVENTION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ANEURYSM EMBOLIZATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ANEURYSM EMBOLIZATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ANEURYSM EMBOLIZATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY STROKE THROMBECTOMY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY STROKE THROMBECTOMY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY STROKE THROMBECTOMY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ONCOLOGY INTERVENTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ONCOLOGY INTERVENTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ONCOLOGY INTERVENTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ONCOLOGY INTERVENTION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY TRANSARTERIAL CHEMOEMBOLIZATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY TRANSARTERIAL CHEMOEMBOLIZATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY TRANSARTERIAL CHEMOEMBOLIZATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY TUMOR ABLATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY TUMOR ABLATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY TUMOR ABLATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY TUMOR ABLATION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY CRYOABLATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY CRYOABLATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY CRYOABLATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY MICROWAVE ABLATION DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY MICROWAVE ABLATION DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY MICROWAVE ABLATION DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY PAIN MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY PAIN MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY VASCULAR INTERVENTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY VASCULAR INTERVENTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY VASCULAR INTERVENTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY DISTRIBUTOR SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY DISTRIBUTOR SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY DISTRIBUTOR SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 103. AMERICAS INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 104. AMERICAS INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 105. AMERICAS INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ABLATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 106. AMERICAS INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY EMBOLIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 107. AMERICAS INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY VASCULAR STENTS, 2018-2032 (USD MILLION)
  • TABLE 108. AMERICAS INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 109. AMERICAS INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY NEURO INTERVENTION, 2018-2032 (USD MILLION)
  • TABLE 110. AMERICAS INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ONCOLOGY INTERVENTION, 2018-2032 (USD MILLION)
  • TABLE 111. AMERICAS INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY TUMOR ABLATION, 2018-2032 (USD MILLION)
  • TABLE 112. AMERICAS INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 113. AMERICAS INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 114. NORTH AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. NORTH AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 116. NORTH AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ABLATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 117. NORTH AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY EMBOLIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 118. NORTH AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY VASCULAR STENTS, 2018-2032 (USD MILLION)
  • TABLE 119. NORTH AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 120. NORTH AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY NEURO INTERVENTION, 2018-2032 (USD MILLION)
  • TABLE 121. NORTH AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ONCOLOGY INTERVENTION, 2018-2032 (USD MILLION)
  • TABLE 122. NORTH AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY TUMOR ABLATION, 2018-2032 (USD MILLION)
  • TABLE 123. NORTH AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 124. NORTH AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 125. LATIN AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 126. LATIN AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 127. LATIN AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ABLATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 128. LATIN AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY EMBOLIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 129. LATIN AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY VASCULAR STENTS, 2018-2032 (USD MILLION)
  • TABLE 130. LATIN AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 131. LATIN AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY NEURO INTERVENTION, 2018-2032 (USD MILLION)
  • TABLE 132. LATIN AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ONCOLOGY INTERVENTION, 2018-2032 (USD MILLION)
  • TABLE 133. LATIN AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY TUMOR ABLATION, 2018-2032 (USD MILLION)
  • TABLE 134. LATIN AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 135. LATIN AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE, MIDDLE EAST & AFRICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE, MIDDLE EAST & AFRICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE, MIDDLE EAST & AFRICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ABLATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE, MIDDLE EAST & AFRICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY EMBOLIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE, MIDDLE EAST & AFRICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY VASCULAR STENTS, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE, MIDDLE EAST & AFRICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE, MIDDLE EAST & AFRICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY NEURO INTERVENTION, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPE, MIDDLE EAST & AFRICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ONCOLOGY INTERVENTION, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE, MIDDLE EAST & AFRICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY TUMOR ABLATION, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE, MIDDLE EAST & AFRICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPE, MIDDLE EAST & AFRICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPE INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPE INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ABLATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPE INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY EMBOLIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY VASCULAR STENTS, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPE INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY NEURO INTERVENTION, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ONCOLOGY INTERVENTION, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPE INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY TUMOR ABLATION, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPE INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPE INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 158. MIDDLE EAST INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 159. MIDDLE EAST INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 160. MIDDLE EAST INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ABLATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 161. MIDDLE EAST INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY EMBOLIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 162. MIDDLE EAST INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY VASCULAR STENTS, 2018-2032 (USD MILLION)
  • TABLE 163. MIDDLE EAST INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 164. MIDDLE EAST INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY NEURO INTERVENTION, 2018-2032 (USD MILLION)
  • TABLE 165. MIDDLE EAST INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ONCOLOGY INTERVENTION, 2018-2032 (USD MILLION)
  • TABLE 166. MIDDLE EAST INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY TUMOR ABLATION, 2018-2032 (USD MILLION)
  • TABLE 167. MIDDLE EAST INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 168. MIDDLE EAST INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 169. AFRICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 170. AFRICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 171. AFRICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ABLATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 172. AFRICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY EMBOLIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 173. AFRICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY VASCULAR STENTS, 2018-2032 (USD MILLION)
  • TABLE 174. AFRICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 175. AFRICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY NEURO INTERVENTION, 2018-2032 (USD MILLION)
  • TABLE 176. AFRICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ONCOLOGY INTERVENTION, 2018-2032 (USD MILLION)
  • TABLE 177. AFRICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY TUMOR ABLATION, 2018-2032 (USD MILLION)
  • TABLE 178. AFRICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 179. AFRICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 180. ASIA-PACIFIC INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 181. ASIA-PACIFIC INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 182. ASIA-PACIFIC INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ABLATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 183. ASIA-PACIFIC INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY EMBOLIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 184. ASIA-PACIFIC INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY VASCULAR STENTS, 2018-2032 (USD MILLION)
  • TABLE 185. ASIA-PACIFIC INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 186. ASIA-PACIFIC INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY NEURO INTERVENTION, 2018-2032 (USD MILLION)
  • TABLE 187. ASIA-PACIFIC INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ONCOLOGY INTERVENTION, 2018-2032 (USD MILLION)
  • TABLE 188. ASIA-PACIFIC INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY TUMOR ABLATION, 2018-2032 (USD MILLION)
  • TABLE 189. ASIA-PACIFIC INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 190. ASIA-PACIFIC INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 191. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 192. ASEAN INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 193. ASEAN INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 194. ASEAN INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ABLATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 195. ASEAN INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY EMBOLIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 196. ASEAN INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY VASCULAR STENTS, 2018-2032 (USD MILLION)
  • TABLE 197. ASEAN INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 198. ASEAN INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY NEURO INTERVENTION, 2018-2032 (USD MILLION)
  • TABLE 199. ASEAN INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ONCOLOGY INTERVENTION, 2018-2032 (USD MILLION)
  • TABLE 200. ASEAN INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY TUMOR ABLATION, 2018-2032 (USD MILLION)
  • TABLE 201. ASEAN INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 202. ASEAN INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 203. GCC INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 204. GCC INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 205. GCC INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ABLATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 206. GCC INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY EMBOLIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 207. GCC INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY VASCULAR STENTS, 2018-2032 (USD MILLION)
  • TABLE 208. GCC INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 209. GCC INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY NEURO INTERVENTION, 2018-2032 (USD MILLION)
  • TABLE 210. GCC INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ONCOLOGY INTERVENTION, 2018-2032 (USD MILLION)
  • TABLE 211. GCC INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY TUMOR ABLATION, 2018-2032 (USD MILLION)
  • TABLE 212. GCC INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 213. GCC INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 214. EUROPEAN UNION INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 215. EUROPEAN UNION INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 216. EUROPEAN UNION INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ABLATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 217. EUROPEAN UNION INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY EMBOLIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 218. EUROPEAN UNION INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY VASCULAR STENTS, 2018-2032 (USD MILLION)
  • TABLE 219. EUROPEAN UNION INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 220. EUROPEAN UNION INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY NEURO INTERVENTION, 2018-2032 (USD MILLION)
  • TABLE 221. EUROPEAN UNION INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ONCOLOGY INTERVENTION, 2018-2032 (USD MILLION)
  • TABLE 222. EUROPEAN UNION INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY TUMOR ABLATION, 2018-2032 (USD MILLION)
  • TABLE 223. EUROPEAN UNION INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 224. EUROPEAN UNION INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 225. BRICS INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 226. BRICS INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 227. BRICS INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ABLATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 228. BRICS INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY EMBOLIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 229. BRICS INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY VASCULAR STENTS, 2018-2032 (USD MILLION)
  • TABLE 230. BRICS INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 231. BRICS INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY NEURO INTERVENTION, 2018-2032 (USD MILLION)
  • TABLE 232. BRICS INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ONCOLOGY INTERVENTION, 2018-2032 (USD MILLION)
  • TABLE 233. BRICS INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY TUMOR ABLATION, 2018-2032 (USD MILLION)
  • TABLE 234. BRICS INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 235. BRICS INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 236. G7 INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 237. G7 INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 238. G7 INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ABLATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 239. G7 INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY EMBOLIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 240. G7 INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY VASCULAR STENTS, 2018-2032 (USD MILLION)
  • TABLE 241. G7 INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 242. G7 INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY NEURO INTERVENTION, 2018-2032 (USD MILLION)
  • TABLE 243. G7 INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ONCOLOGY INTERVENTION, 2018-2032 (USD MILLION)
  • TABLE 244. G7 INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY TUMOR ABLATION, 2018-2032 (USD MILLION)
  • TABLE 245. G7 INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 246. G7 INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 247. NATO INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 248. NATO INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 249. NATO INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ABLATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 250. NATO INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY EMBOLIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 251. NATO INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY VASCULAR STENTS, 2018-2032 (USD MILLION)
  • TABLE 252. NATO INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 253. NATO INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY NEURO INTERVENTION, 2018-2032 (USD MILLION)
  • TABLE 254. NATO INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ONCOLOGY INTERVENTION, 2018-2032 (USD MILLION)
  • TABLE 255. NATO INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY TUMOR ABLATION, 2018-2032 (USD MILLION)
  • TABLE 256. NATO INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 257. NATO INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 258. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 259. UNITED STATES INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 260. UNITED STATES INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 261. UNITED STATES INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ABLATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 262. UNITED STATES INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY EMBOLIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 263. UNITED STATES INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY VASCULAR STENTS, 2018-2032 (USD MILLION)
  • TABLE 264. UNITED STATES INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 265. UNITED STATES INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY NEURO INTERVENTION, 2018-2032 (USD MILLION)
  • TABLE 266. UNITED STATES INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ONCOLOGY INTERVENTION, 2018-2032 (USD MILLION)
  • TABLE 267. UNITED STATES INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY TUMOR ABLATION, 2018-2032 (USD MILLION)
  • TABLE 268. UNITED STATES INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 269. UNITED STATES INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 270. CHINA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 271. CHINA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 272. CHINA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ABLATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 273. CHINA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY EMBOLIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 274. CHINA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY VASCULAR STENTS, 2018-2032 (USD MILLION)
  • TABLE 275. CHINA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 276. CHINA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY NEURO INTERVENTION, 2018-2032 (USD MILLION)
  • TABLE 277. CHINA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ONCOLOGY INTERVENTION, 2018-2032 (USD MILLION)
  • TABLE 278. CHINA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY TUMOR ABLATION, 2018-2032 (USD MILLION)
  • TABLE 279. CHINA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 280. CHINA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)